Non-pharmacological options are often sought to manage behavioural symptoms in dementia. Reverie VR offers supervised, single-user sessions that provide calming visual experiences, which may help reduce the reliance on medications for managing agitation and anxiety.

The Importance of Reducing Medication Use

Minimising medication can lower the risk of side effects, fostering a more natural and holistic approach to care.

How Reverie VR Supports Non-Pharmacological Intervention:

• Calming Visuals: Immersive, soothing environments help ease agitation.

• Supervised Sessions: Carer oversight ensures that each session is safely managed.

• Complementary Approach: VR therapy can be integrated with existing care strategies to reduce the need for medication.

Scientific Evidence:

1. Journal of Alzheimer’s Disease (2020) documents positive behavioural improvements with VR interventions (j-alz.com).

2. International Journal of Geriatric Psychiatry (2020) reports that non-pharmacological methods can decrease medication reliance (onlinelibrary.wiley.com).

3. BMJ Open (2021) supports digital therapies in managing agitation (bmjopen.bmj.com).

Implementing Reverie VR:

• Family Carers: Consult with care professionals about integrating VR to complement medication regimens.

• Home Carers: Monitor and document behavioural changes during supervised sessions.

• Review: Use outcome data to discuss potential adjustments in medication with healthcare providers.

Explore how Reverie VR can serve as a calming alternative. Contact us for more details.